Meet the Bionic Vision Technologies Executive Management Team

 

Ash Attia

Chief Executive Officer

Ash Attia, PhD, FAICD  Ash has more than 30 years of senior executive management experience in implantable devices and biotechnology. Prior to BVT, Ash held the position of Vice President Asia Pacific, the Middle East and Israel, at TransMedics Inc. Ash also held Vice President and Managing Director roles within several other major Australian and International medtech organizations such as Thoratec, St Jude Medical, Micromed, Syncardia, Ventracor, Biotronik, SulzerMedica and Telectronics. Ash has extensive experience in medical technology commercialization, general management, research and development, marketing, market entry strategies, regulatory and reimbursement across multiple geographies (USA, Asia Pacific and Europe). He is also a Fellow of the Australian Institute of Company Directors and has extensive governance experience being a Non-Executive Director on the board of ASX-listed Company DorsaVi for over 10 years.

Qualifications

BSc (E.Eng/Med Eng with Honors)
MSc (Med. Eng)
PhD (Med. Sc)
FAICD

Jul 2019 – present

  • 30+ years of senior executive management experience in implantable devices and biotechnology.
  • Vice President and Managing Director roles with global medical devices organizations including TransMedics, St. Jude Medical, Thoratec, Syncardia,Ventarcor, Biotronik, SulzerMedica, and Telectronics/Nucleus Group.
  • Extensive experience in Class III medical devices commercialization including market entry strategies, R&D, Clinical, Regulatory, Reimbursement, General Management and Global Expansion.

 

Brian Gordon

Chief Technology Officer

Brian Gordon, MBA  Brian Gordon joined BVT in January 2019 as Chief Technology Officer. Brian joined us from Cochlear Ltd where he had held various senior engineering roles including most recently the position of Senior Portfolio Manager, Implants. Brian was responsible for delivery of Cochlear’s new implant projects to market.

Qualifications

BEng (Electrical with Honors)
BCommerce (Marketing / Economics)
MBA
PMP

Jan 2019 – present

  • 20 years experience of new product development in implantable medical devices and the electronics industry.
  • Senior leadership roles at market leading companies including Cochlear & RØDE Microphones.
  • Recently the Senior Portfolio Manager at Cochlear responsible for delivery of new implantable systems to global market.
  • Extensive experience in bringing Class III medical devices to market in highly regulated environments.

 

 

Adrian Oates

Chief Operating Officer

Adrian Oates, PhD  Adrian joined BVT in March 2019 as Chief Operating Officer. Adrian has more than 25 years of senior executive experience in the medical device, in-vitro diagnostic, biological and pharmaceutical health care industries at major companies including Cochlear and CSL Behring.

Qualifications

BSc (Biochemistry/ Microbiology)
MSc (Biochemistry)
PhD (Medicine)

 

Mar 2019 – present

  • 25+ years experience of leadership roles in the medical device, in-vitro diagnostic, biological and pharmaceutical health care industries.
  • Vice President and Director level roles at global companies including Cochlear, CSL Behring and Universal Biosensors.
  • Extensive experience across quality, regulatory, clinical & operations in highly regulated environments including Class III implantable medical devices

Meet the Bionic Vision Technologies Board

The Board of Bionic Vision Technologies is responsible for oversight of the management of the company and providing strategic direction. The members of the Board have a great depth of experience in commercialization of medical technologies and corporate finance.

The Management of Bionic Vision Technologies is responsible for business operations including product development, regulatory and commercialization

 

Ergad Gold

Chairman

Ergad Gold, PhD  Ergad Gold is a Principal and Director of the Momentum venture capital group and has many years’ experience in product development and commercialisation spanning a wide range of technologies. He has worked extensively in industry, government and academia and for six years operated his own consulting practice specialising in technology management. Within the Momentum portfolio, Ergad is currently a Director of CR-X Pty Ltd and Retriever Communications Pty Ltd. He was formerly a Director of EnGeneIC Ltd, Panviva Pty Ltd and Biovend Pty Ltd. He is also a Director of the Cooperative Research Centre for Polymers and also serves on commercialisation advisory committees at the Florey Neurosciences Institute and the Bionics Institute.

Qualifications

BSc (Hons)
PhD

 

Ash Attia

Chief Executive Officer

Ash Attia, PhD, FAICD  Ash Attia has over 30 years of senior executive management experience in implantable devices and biotechnology. Prior to BVT, Ash held the position of Vice President Asia Pacific, the Middle East and Israel, at TransMedics Inc. Ash also held Vice President and Managing Director roles within several other major Australian and International medtech organizations such as Thoratec, St Jude Medical, Micromed, Syncardia, Ventracor, Biotronik, SulzerMedica and Telectronics. Ash has extensive experience in medical technology commercialization, general management, research and development, marketing, market entry strategies, regulatory and reimbursement across multiple geographies (USA, Asia Pacific and Europe). He is also a Fellow of the Australian Institute of Company Directors and has extensive governance experience being a Non-Executive Director on the board of ASX-listed Company DorsaVi for over 10 years.

Qualifications

BSc (E.Eng/Med Eng with Honors)
MSc (Med. Eng)
PhD (Med. Sc)
FAICD

 

Jim Henderson

Director

Jim Henderson, PhD, RTTP, GAICD   Jim has a long association with technology commercialisation and recently has been increasingly focused on deep tech start up companies.  Appointed as CEO of Sydney based Nano Bubble Technologies in early 2019, Jim is driving NBT’s transition from a R&D company in the industrial gasses space to a revenue generating operation with products on the market.   Jim is also providing strategic support to other start ups. As a Director of Bionic Vision Technologies, QD Solar, MEDAD Technologies, and NOMADD Desert Solutions, Jim is supporting each management team to build shareholder value by maintaining focus and pragmatically making strong commercial decisions.   Jim was Chief Operating Officer of UNSW Innovations from 2011 to 2017, and its General Manager from 2007 – 2011.  During these periods he worked extensively with UNSW’s School of Photovoltaic and Renewable Energy, a world leader in developing industry relevant Silicon PV technologies and solutions.  Separate from PV, Jim led UNSW’s most complex technology commercialisation deals, including structuring and closing a $20m Joint Venture with a publicly listed Chinese partner.  He previously held technology licensing positions with the University of California San Francisco and the University of Utah.   Jim was a member of the Uniseed Biotechnology Investment Committee from 2007 – 2015.  Uniseed is a pre-seed and seed stage venture capital firm supported by CSIRO and the Universities of Queensland, Sydney, Melbourne and UNSW Sydney.   Jim holds a PhD in Molecular Biology from the University of Utah; is a Registered Technology Transfer Professional; and is a graduate of the Australian Institute of Company Directors.

Qualifications

PhD (University of Utah)

 

Alastair Lam

Director

Alastair was the Founder of Synergy Group and responsible for formulating its overall corporate strategies and management directions. Mr. Lam served as a Non-Executive Director at Synergy Group Holdings International Ltd. from December 14, 2011 to December 19, 2016. Mr. Lam serves as a Director of Synergy Lighting Limited and Synergy Group Worldwide Limited. From 2001 to 2006, Mr. Lam was the accounting executive in Qualipak Manufacturing Limited, a then wholly owned subsidiary of Qualipak International Holdings Limited, a company listed on the Main Board of the Stock Exchange.

 

Alan Kwan

Director

Mr. Alan Kwan is the Executive Director of State Path Capital.
State Path is headed by executive director Alan Kwan and chaired by Alastair Lam, the nephew of Hong Kong’s richest person Li Ka-shing whose net worth is valued at nearly $US30 billion, according to Forbes.
Dianne Angus

 

Dianne Angus

Non-Executive Director

Dianne has worked as a senior executive within the biotechnology, pharmaceutical, agritech, medical device and healthcare sectors for over twenty years and currently serves as non-executive director with Neuren Pharmaceuticals Limited (ASX: NEU) and Imagion Biosystems (ASX: IBX). She has built competitive and differentiated product portfolios, from investment in innovative research and product development to commercialisation and market entry. Dianne has created many global industry partnerships to accelerate asset development, attract financing and provide reputational validation & endorsement. With eighteen years’ experience in ASX and NASDAQ listed companies, Dianne has expertise in corporate governance, capital raising and stakeholder engagement within the listed capital market sector. Dianne is a member of the Australian Institute of Company Directors and is a registered patent & trademark attorney.

Qualifications

B.Sc. Hons. (Zoology/Genetics)
M. Biotechnology (Chem Eng.)
Grad Dip. IP Law

 

Brendan Case

Company Secretary

Brendan Case is the Managing Director of Case Governance. He is a Chartered Secretary, has a Masters of Commercial Law from The University of Melbourne and has degrees in both Economics and Finance. Brendan has more than 25 years of company secretarial, corporate governance and finance experience. He is a former Associate Company Secretary of National Australia Bank Limited. Brendan is currently the Company Secretary of three companies listed on the ASX and is a non-executive director of a number of private companies. Case Governance also provides services to organisations based offshore which have established Australian entities to conduct medical research in Melbourne. 

Qualifications

MComLaw (Melb)
BEc
CPA
FGIA
MAICD